Informed deferral: a moral requirement for entry into the hepatitis C virus treatment warehouse
Hepatology
.
2012 Nov;56(5):1591-2.
doi: 10.1002/hep.25957.
Authors
Andrew Aronsohn
,
Donald Jensen
PMID:
22807004
DOI:
10.1002/hep.25957
No abstract available
Publication types
Editorial
MeSH terms
Antiviral Agents / therapeutic use*
Hepatitis C / drug therapy*
Humans
Informed Consent / ethics*
Patient Participation*
Physician-Patient Relations / ethics
Time Factors
Truth Disclosure / ethics
Substances
Antiviral Agents